price disclosure
Generics granted price increases
Around 60 generic medicines have been granted price increases this month, including a 133% increase for a common antibiotic Through the Generic Medicines Working Group, the Generic and Biosimilar Medicines Association …
Questions to start early on 1 Oct price cuts
The Health Minister’s early announcement regarding 1 October price cuts means customers may start asking questions already, says Pharmacy Guild Yesterday Sussan Ley announced that more than 2000 medicine brands …
Price reduction for combinations
A range of combination medicines are due to experience price cuts in the 1 October round of price disclosure measures. The newly advised cuts will affect combination drugs due to …
The Slap: bearing pharmacy’s pain
Pharmacy is under a lot of pressure, writes Mouhamad Zoghbi—but does keeping worries to yourself help your team? I’d like tell you about something that happened at my home recently. …
The price isn’t right
Statins to experience further price disclosure hit A number of the most commonly used medicines are going to experience additional price drops in the newly released October price disclosure cycle. …
Falling PBS script prices force pharmacies to boost retail revenue
PBS reform is forcing pharmacy operators to boost their retail revenue, a report from IBISWorld, Pharmacies in 2016-7, shows. The report, which warns of troubled times ahead for pharmacy, says …
Medicines cost to drop by up to half
The cost of everyday medicines is set to drop by up to half from October 2016, Sussan Ley said in a statement regarding the 2016 Budget today. “Access to vital …
Apotex decision a warning bell
Apotex’ decision to pull two of its PBS-listed products should ring an alarm for the health and pharmaceuticals sector, says Belinda Wood, CEO of the Generic and Biosimilar Medicines Association. …
Apotex pulls products as price reductions bite
Apotex has announced that it will be ceasing supply of two PBS listed prescription products from its portfolio. The PBS delisting date is yet to be confirmed, and stock will …
Pharmacy not getting credit it deserves: Quilty
Pharmacy is not getting the credit it deserves in creating savings through PBS reforms, Guild executive director David Quilty writes in this week’s edition of Forefront – and so it …
Medicines sector reforms deliver consumer benefits and a sustainable PBS
Consumers, taxpayers and the national health system will benefit from the significant savings being delivered by medicine suppliers since 1 April, say Medicines Australia, the Generic and Biosimilar Medicines Association, …
Delistings, shortages looming as discount well runs dry
Pharmacy is set to see more delistings and stock shortages this year as a result of simplified price disclosure, GBMA president Belinda Wood warned over the weekend. Presenting at APP2016, …